• Home   ›
  •   Global Tenders   › Tender Reference No: 92016928

    • Bids Are Invited For Eventual Acquisition Of Chemotherapeutic Medicines

    Tender Detail

    92016928
    You can view only after subscription.
    PE-001/25/2025
    Self-Funded
    Bids Are Invited For Eventual Acquisition Of Chemotherapeutic Medicines
    NCB
    You can view only after subscription.
    South America
    BRIC,G20
    17-02-2025

    Work Detail

    Pharmacological Group: Antineoplastic Antimetabolic, Active Principle: Friendly, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 350, Unit: Mg, Volume: 7 Ml, Presentation: Vial, Accessory: N / A, Form Supply: Unit, Group Pharmacological: Monoclonal Antibody, Active Principle: Ipilimumab, Concentration / Dosage: 5, Unit: Mg / Ml, Volume: 40 Ml, Presentation: Ampoule Bottle, Volume: 10 Ml, Pharmacological Group: Antineoplastic, Active Principle: Cable Levomalato, Form Pharmaceutical: Coated Tablet, Concentration/Dosage: 60, Volume: N/A, Presentation: N/A, Concentration/Dosage: 40, 01/31/2025

    Key Value

    Tender Value
    38,54,809 - BRL

    Attachment

    FileName File Description
    Global Tender Document Tender Notice
    Attachments
    Click Here To Download
    Tender Documents

    Additional Details Available on Click
    ✓ Tendering Authority
    ✓ Publication Document
    (Tender Document / Tender Notice )
    Disclaimer :
    We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
    Tell us about your Product / Services,
    We will Find Tenders for you
    Cnet Technologies

    We are a group of professionals specializing in custom software development, web development, mobile app development, IOT base solutions, web design, graphics & Enterprise solutions provid.

    About Us

    Services

    Browse Tenders

    For Sales Inquiry

    Connect With Us

    Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

    For Tender Information Services Visit : TenderDetail